MedTrace Logo

Nexplanon Use in Women Primarily Choosing a Combined Oral Contraceptive

NCT04423055 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2024-05-22

No results posted yet for this study

Summary

Women currently using or starting a combined oral contraceptive (COC) will be offered study enrollment. Study subjects will have a Nexplanon placed and followed for approximately 12 months to evaluate if they continue the implant, the COC, or both, and to assess bleeding patterns and adverse events.

Conditions

  • Contraception

Interventions

DRUG

Etonogestrel contraceptive implant

Place etonogestrel contraceptive implant.

Sponsors & Collaborators

Principal Investigators

  • Melissa C Matulich, MD MAS · University of California, Davis

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-13
Primary Completion
2024-04-09
Completion
2024-04-09
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04423055 on ClinicalTrials.gov